INVO Bioscience, Inc.·4

Jan 18, 9:26 PM ET

Goren Andrea 4

4 · INVO Bioscience, Inc. · Filed Jan 18, 2022

Insider Transaction Report

Form 4
Period: 2022-01-15
Goren Andrea
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-01-15+5,36117,861 total
  • Award

    Stock Option

    2022-01-15+15,19715,197 total
    Exercise: $3.61Exp: 2032-01-14Common Stock (15,197 underlying)
Holdings
  • Common Stock

    5,000
  • Common Stock

    (indirect: By LLC)
    76,383
Footnotes (2)
  • [F1]Represents an award of restricted stock units which vest in substantially equal monthly increments over a period of 12 months from the date of grant of July 1, 2021
  • [F2]The stock option vests in monthly increments over a period of three years from the date of grant.

Documents

1 file
  • 4
    ownership.xmlPrimary